Alert

Recommended Alerts

Sign Up For Alerts

Congress Enacts Clean Reauthorization of FDA User Fees, Leaving Uncertain Future for Important Policy Reforms

On September 30, 2022, Congress passed a short-term continuing resolution (“CR”), H.R. 6833, as a temporary stopgap measure to continue funding the U.S. government past the end of the fiscal year.

Read More

Cookie Settings